UBS flagged McKesson (NYSE:MCK) for expanding in oncology and multispecialty care through recent deal activity. The firm pointed to McKesson's agreement to acquire Precision Medicine Group to deepen ...
Source LinkUBS flagged McKesson (NYSE:MCK) for expanding in oncology and multispecialty care through recent deal activity. The firm pointed to McKesson's agreement to acquire Precision Medicine Group to deepen ...
Source Link
Comments